This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qin, L.-X. Articles by Guan, X.-Y. Search for Related Content PubMed PubMed Citation Articles by Qin, L.-X. Articles by Guan, X.-Y.

The Association of Chromosome 8p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma¹

Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical University, Shanghai, Peoples Republic of China [L-X. Q., Z-Y. T., Z-C. M., S-L. Y., X-D. Z., Z-Q. W.]; Department of Clinical Oncology, Queen Mary Hospital, University of Hong Kong, Hong Kong [J. S. T. S., X-Y. G.]; and Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland [J. M. T.]

To understand the genetic mechanisms underlying the progression of hepatocellular carcinoma (HCC) metastasis, differences of genomic alterations between 10 pairs of primary HCC tumors and their matched metastatic lesions were analyzed by comparative genomic hybridization. Several chromosomal alterations including loss of 8p, 4q, 17p, and 19p, gain of 5p and high-level amplification of 1q12-q22 were detected in two or more cases. The most significant finding is the loss of 8p which was detected in 8 metastatic tumors but only in 3 corresponding primary tumors (P = 0.03). This result suggests that the deletion of chromosome 8p might contribute to the development of HCC metastasis. Another interesting result is the detection of a minimum high-level amplification region at 1q12-q22 in HCC. This result provides a candidate amplification region in HCC for further study to identify amplified oncogenes related to the development or progression of HCC. Finally, this study provides a practicable model to detect specific genetic alterations related to the tumor metastasis through comparing the primary tumor and its corresponding metastatic lesion using comparative genomic hybridization technique.

This article has been cited by other articles:

				J. M.-F. Lee, C.-M. Wong, and I. O.-L. Ng Hepatitis B Virus-Associated Multistep Hepatocarcinogenesis: A Stepwise Increase in Allelic Alterations Cancer Res., July 15, 2008; 68(14): 5988 - 5996. [Abstract] [Full Text] [PDF]

				J.-Z. Pang, L.-X. Qin, N. Ren, Z.-Y. Hei, Q.-H. Ye, W.-D. Jia, B.-S. Sun, G.-L. Lin, D.-Y. Liu, Y.-K. Liu, et al. Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7363 - 7369. [Abstract] [Full Text] [PDF]

				F. Rubio-Moscardo, D. Blesa, C. Mestre, R. Siebert, T. Balasas, A. Benito, A. Rosenwald, J. Climent, J. I. Martinez, M. Schilhabel, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes Blood, November 1, 2005; 106(9): 3214 - 3222. [Abstract] [Full Text] [PDF]

				G. M. Caldwell, C. Jones, K. Gensberg, S. Jan, R. G. Hardy, P. Byrd, S. Chughtai, Y. Wallis, G. M. Matthews, and D. G. Morton The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis Cancer Res., February 1, 2004; 64(3): 883 - 888. [Abstract] [Full Text] [PDF]

				N. Wong, W.-C. Lam, P. B.-S. Lai, E. Pang, W.-Y. Lau, and P. J. Johnson Hypomethylation of Chromosome 1 Heterochromatin DNA Correlates with q-Arm Copy Gain in Human Hepatocellular Carcinoma Am. J. Pathol., August 1, 2001; 159(2): 465 - 471. [Abstract] [Full Text]

				I. O.-l. Ng, Z.-d. Liang, L. Cao, and T. K.-w. Lee DLC-1 Is Deleted in Primary Hepatocellular Carcinoma and Exerts Inhibitory Effects on the Proliferation of Hepatoma Cell Lines with Deleted DLC-1 Cancer Res., December 1, 2000; 60(23): 6581 - 6584. [Abstract] [Full Text]

				N. Wong, P. Lai, E. Pang, L.-F. Fung, Z. Sheng, V. Wong, W. Wang, Y. Hayashi, E. Perlman, S. Yuna, et al. Genomic Aberrations in Human Hepatocellular Carcinomas of Differing Etiologies Clin. Cancer Res., October 1, 2000; 6(10): 4000 - 4009. [Abstract] [Full Text]